Insider Transactions in Q4 2024 at Procept Bio Robotics Corp (PRCT)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 20
2024
|
Reza Zadno President, CEO |
SELL
Open market or private sale
|
Direct |
26,420
-3.91%
|
$2,430,640
$92.94 P/Share
|
Nov 13
2024
|
Reza Zadno President, CEO |
SELL
Open market or private sale
|
Direct |
26,420
-2.65%
|
$2,483,480
$94.23 P/Share
|
Nov 07
2024
|
Antal Rohit Desai Director |
SELL
Open market or private sale
|
Indirect |
34,000
-4.54%
|
$3,230,000
$95.83 P/Share
|
Nov 06
2024
|
Antal Rohit Desai Director |
SELL
Open market or private sale
|
Indirect |
33,000
-3.74%
|
$3,201,000
$97.03 P/Share
|
Nov 05
2024
|
Antal Rohit Desai Director |
SELL
Open market or private sale
|
Indirect |
33,000
-3.27%
|
$3,168,000
$96.87 P/Share
|
Nov 05
2024
|
Antal Rohit Desai Director |
SELL
Other acquisition or disposition
|
Indirect |
895,262
-100.0%
|
-
|
Oct 30
2024
|
Reza Zadno President, CEO |
SELL
Open market or private sale
|
Direct |
288,461
-52.74%
|
$26,249,951
$91.0 P/Share
|
Oct 30
2024
|
Reza Zadno President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
288,461
+34.53%
|
$1,153,844
$4.37 P/Share
|
Oct 15
2024
|
Kevin Waters EVP, CFO |
SELL
Open market or private sale
|
Direct |
25,000
-7.28%
|
$1,800,000
$72.96 P/Share
|
Oct 15
2024
|
Kevin Waters EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+17.11%
|
$100,000
$4.56 P/Share
|